Ruxolitinib is a Janus kinase (JAK) 1/JAK2 inhibitor, a type of targeted immune therapy that…
DigitalFebruary 13, 2026
1 | INTRODUCTION Anxiety and depressive disorders are the most common psychopathologies in children and adolescents.1 Alopecia…
SimbotiAugust 18, 2023
April 20, 2023 at 10:21 AM EDT Opzelura® (ruxolitinib) Cream is the first approved treatment in…
SimbotiAugust 18, 2023
